IRONORM

One capsule to be taken by mouth three times a day with meals.

System Organ Class Very Common (≥1/10) Common ≥1/100, < 1/10 Uncommon ≥1/1,000, <1/100 Rare ≥1/10,000, <1/1000 Very Rare <1/10,000 Not known (cannot be estimated from available data) Gastrointestinal Disorders Nausea and vomiting Gastrointestinal discomfort Constipation Diarrhoea Discoloured (dark) stools Immune System Disorders Allergic reactions System Organ Class Very Common (≥1/10) Common ≥1/100, < 1/10 Uncommon ≥1/1,000, <1/100 Rare ≥1/10,000, <1/1000 Very Rare <1/10,000 Not known (cannot be estimated from available data) Metabolism and Nutrition disorders Anorexia Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.

It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard

Use with caution in the presence of Haemochromatosis, Haemolytic Anaemias and Haemoglobinopathies.

The label will state “Important warning:

Contains iron. Keep out of the sight and reach of children, as overdose may be fatal”. This will appear on the front of the pack within a rectangle in which there is no other information. Patients with rare hereditary problems of fructose intolerance should not take this medicine.

Ironorm capsules contain soya oil. If you are allergic to peanut or soya, do not use this medicinal product.

1. Hypersensitivity to peanut or soya.